Literature DB >> 26286750

The capsule polymerase CslB of Neisseria meningitidis serogroup L catalyzes the synthesis of a complex trimeric repeating unit comprising glycosidic and phosphodiester linkages.

Christa Litschko1, Maria Rosaria Romano2, Vittoria Pinto2, Heike Claus3, Ulrich Vogel3, Francesco Berti2, Rita Gerardy-Schahn1, Timm Fiebig4.   

Abstract

Neisseria meningitidis is a human pathogen causing bacterial meningitis and sepsis. The capsular polysaccharide surrounding N. meningitidis is a major virulence factor. The capsular polysaccharide consists of polyhexosamine phosphates in N. meningitidis serogroups A and X. The capsule polymerases (CPs) of these serogroups are members of the Stealth protein family comprising d-hexose-1-phosphate transferases from bacterial and protozoan pathogens. CslA, one of two putative CPs of the pathophysiologically less relevant N. meningitidis serogroup L, is one of the smallest known Stealth proteins and caught our attention for structure-function analyses. Because the N. meningitidis serogroup L capsule polymer consists of a trimeric repeating unit ([→3)-β-d-GlcNAc-(1→3)-β-d-GlcNAc-(1→3)-α-d-GlcNAc-(1→OPO3→]n), we speculated that the two predicted CPs (CslA and CslB) work together in polymer production. Consequently, both enzymes were cloned, overexpressed, and purified as recombinant proteins. Contrary to our expectation, enzymatic testing identified CslB to be sufficient to catalyze the synthesis of the complex trimeric N. meningitidis serogroup L capsule polymer repeating unit. No polymerase activity was detected for CslA, although the enzyme facilitated the hydrolysis of UDP-GlcNAc. Bioinformatics analyses identified two glycosyltransferase (GT) domains in CslB. The N-terminal domain modeled with 100% confidence onto a number of GT-A folded proteins, whereas the C-terminal domain modeled with 100% confidence onto TagF, a GT-B folded teichoic acid polymerase from Staphylococcus epidermidis. Amino acid positions known to have critical catalytic functions in the template proteins were conserved in CslB, and their point mutation abolished enzyme activity. CslB represents an enzyme of so far unique complexity regarding both the catalyzed reaction and enzyme architecture.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CslB; Neisseria meningitidis; bifunctional enzyme; capsule polymerase; glycosyltransferase; hexose-1-phosphate transferase; high-performance liquid chromatography (HPLC); nuclear magnetic resonance (NMR); polysaccharide; recombinant protein expression

Mesh:

Substances:

Year:  2015        PMID: 26286750      PMCID: PMC4591819          DOI: 10.1074/jbc.M115.678094

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Serogroup W135 meningococcal disease in Hajj pilgrims.

Authors:  M K Taha; M Achtman; J M Alonso; B Greenwood; M Ramsay; A Fox; S Gray; E Kaczmarski
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

Review 2.  Biosynthesis and assembly of capsular polysaccharides in Escherichia coli.

Authors:  Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

Review 3.  Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

Authors:  David S Stephens
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

4.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

5.  In vitro assays of orphan glycosyltransferases and their application to identify Notch xylosyltransferases.

Authors:  Maya K Sethi; Falk F R Buettner; Angel Ashikov; Hans Bakker
Journal:  Methods Mol Biol       Date:  2013

Review 6.  Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.

Authors:  Ouli Xie; Andrew J Pollard; Judith E Mueller; Gunnstein Norheim
Journal:  Vaccine       Date:  2013-04-24       Impact factor: 3.641

7.  Functional characterization of PmHS1, a Pasteurella multocida heparosan synthase.

Authors:  Tasha A Kane; Carissa L White; Paul L DeAngelis
Journal:  J Biol Chem       Date:  2006-09-07       Impact factor: 5.157

8.  Genetic analysis of the capsule locus of Haemophilus influenzae serotype f.

Authors:  Sarah W Satola; Patricia L Schirmer; Monica M Farley
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Analysis of the two active sites of the hyaluronan synthase and the chondroitin synthase of Pasteurella multocida.

Authors:  Wei Jing; Paul L DeAngelis
Journal:  Glycobiology       Date:  2003-06-10       Impact factor: 4.313

10.  Longer-term psychiatric adjustment of children and parents after meningococcal disease.

Authors:  M Elena Garralda; Julia Gledhill; Simon Nadel; David Neasham; Michael O'Connor; Daniel Shears
Journal:  Pediatr Crit Care Med       Date:  2009-11       Impact factor: 3.624

View more
  10 in total

1.  Efficient solid-phase synthesis of meningococcal capsular oligosaccharides enables simple and fast chemoenzymatic vaccine production.

Authors:  Timm Fiebig; Christa Litschko; Friedrich Freiberger; Andrea Bethe; Monika Berger; Rita Gerardy-Schahn
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

2.  A two-phase model for the non-processive biosynthesis of homogalacturonan polysaccharides by the GAUT1:GAUT7 complex.

Authors:  Robert A Amos; Sivakumar Pattathil; Jeong-Yeh Yang; Melani A Atmodjo; Breeanna R Urbanowicz; Kelley W Moremen; Debra Mohnen
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

3.  Xylan-based nanocompartments orchestrate plant vessel wall patterning.

Authors:  Hang Wang; Hanlei Yang; Zhao Wen; Chengxu Gao; Yihong Gao; Yanbao Tian; Zuopeng Xu; Xiangling Liu; Staffan Persson; Baocai Zhang; Yihua Zhou
Journal:  Nat Plants       Date:  2022-03-22       Impact factor: 15.793

4.  An enzyme-based protocol for cell-free synthesis of nature-identical capsular oligosaccharides from Actinobacillus pleuropneumoniae serotype 1.

Authors:  Insa Budde; Christa Litschko; Jana I Führing; Rita Gerardy-Schahn; Mario Schubert; Timm Fiebig
Journal:  J Biol Chem       Date:  2020-03-09       Impact factor: 5.157

5.  Engineering of GlcNAc-1-Phosphotransferase for Production of Highly Phosphorylated Lysosomal Enzymes for Enzyme Replacement Therapy.

Authors:  Lin Liu; Wang-Sik Lee; Balraj Doray; Stuart Kornfeld
Journal:  Mol Ther Methods Clin Dev       Date:  2017-03-29       Impact factor: 6.698

Review 6.  The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease.

Authors:  Tsitsi D Mubaiwa; Evgeny A Semchenko; Lauren E Hartley-Tassell; Christopher J Day; Michael P Jennings; Kate L Seib
Journal:  Pathog Dis       Date:  2017-07-31       Impact factor: 3.166

7.  A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens.

Authors:  Christa Litschko; Davide Oldrini; Insa Budde; Monika Berger; Jochen Meens; Rita Gerardy-Schahn; Francesco Berti; Mario Schubert; Timm Fiebig
Journal:  mBio       Date:  2018-05-29       Impact factor: 7.867

Review 8.  Nucleotide Sugars in Chemistry and Biology.

Authors:  Satu Mikkola
Journal:  Molecules       Date:  2020-12-06       Impact factor: 4.411

9.  Mix-and-Match System for the Enzymatic Synthesis of Enantiopure Glycerol-3-Phosphate-Containing Capsule Polymer Backbones from Actinobacillus pleuropneumoniae, Neisseria meningitidis, and Bibersteinia trehalosi.

Authors:  Christa Litschko; Insa Budde; Monika Berger; Andrea Bethe; Julia Schulze; E Alberto Alcala Orozco; Reza Mahour; Peter Goettig; Jana Indra Führing; Thomas Rexer; Rita Gerardy-Schahn; Mario Schubert; Timm Fiebig
Journal:  mBio       Date:  2021-05-26       Impact factor: 7.867

10.  An efficient cell free enzyme-based total synthesis of a meningococcal vaccine candidate.

Authors:  Timm Fiebig; Maria Rosaria Romano; Davide Oldrini; Roberto Adamo; Marta Tontini; Barbara Brogioni; Laura Santini; Monika Berger; Paolo Costantino; Francesco Berti; Rita Gerardy-Schahn
Journal:  NPJ Vaccines       Date:  2016-11-15       Impact factor: 7.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.